Emplom Tablets 5/500 mg
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
MFDS item code 202201378 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar levels in adults with Type 2 diabetes. Specifically, the combination of empagliflozin and metformin can effectively manage blood sugar levels. Additionally, it may affect the reduction of cardiovascular event risk in patients with established cardiovascular disease, so it must be used carefully under the guidance of a healthcare professional. This medication helps improve blood sugar control, aiding in diabetes management.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can potentially cause a rare but life-threatening condition known as severe lactic acidosis, so caution is required. When used in conjunction with other diabetes medications, hypoglycemia may occur, so blood sugar levels must be monitored closely. It should not be used in patients with moderate to severe renal impairment or in situations suspecting acute kidney injury. In cases of severe infections, dehydration, or serious health conditions such as heart failure, the administration of this medication should be avoided. Prior to and after undergoing examinations using iodine-based contrast agents, this medication should be temporarily discontinued, and should only be resumed after normal kidney function is confirmed. It is advised that this medication not be used by pregnant or potentially pregnant women and nursing mothers. Since this medication is affected by kidney function, regular kidney function testing is necessary, especially for elderly patients or those with reduced kidney function. Caution is necessary for patients at risk of decreased fluid volume, such as those experiencing dehydration, vomiting, or diarrhea when taking this medication. While taking this medication, be vigilant for symptoms of hypoglycemia, and dose adjustments may be necessary when used in combination with insulin or sulfonylureas due to an increased risk of hypoglycemia. Urinary or genital infections may occur, so consult a physician immediately if related symptoms appear. Long-term use may lower vitamin B12 levels, so it is advisable to monitor through blood tests. Alcohol intake can increase the risk of lactic acidosis, so it is important to avoid excessive drinking while on this medication. If food intake is not possible for a prolonged period due to surgery or significant illness, the use of this medication should be temporarily stopped. Immediate treatment should be sought if symptoms of fever, pain or swelling in the genital area, or perineal necrotic symptoms appear, and medication should be discontinued in such cases. This medication is not recommended for children under 18 years, and patients over 75 years should be cautious due to the risk of fluid loss. In the event of an overdose, seek medical attention promptly, as this medication can be removed through hemodialysis.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent the entry of air or moisture, and it is recommended to be kept at a room temperature of 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness safely.
Biconvex oval film-coated tablets in orange-yellow color
10 tablets/box [(10 tablets/PTP)×1], 60 tablets/box [(10 tablets/PTP)×6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.